220 related articles for article (PubMed ID: 38215151)
1. Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review.
Yao N; Li W; Duan N; Xu G; Yu G; Qu J
Medicine (Baltimore); 2024 Jan; 103(2):e36957. PubMed ID: 38215151
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications.
Fang P; Zhou J; Liang Z; Yang Y; Luan S; Xiao X; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
Front Immunol; 2022; 13():975986. PubMed ID: 36119033
[TBL] [Abstract][Full Text] [Related]
5. Novel immunotherapies for breast cancer: Focus on 2023 findings.
Lan HR; Chen M; Yao SY; Chen JX; Jin KT
Int Immunopharmacol; 2024 Feb; 128():111549. PubMed ID: 38266449
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.
Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J
Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928
[TBL] [Abstract][Full Text] [Related]
7. The State of Immunotherapy in Hepatobiliary Cancers.
Ilyas FZ; Beane JD; Pawlik TM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
[TBL] [Abstract][Full Text] [Related]
8. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
Saleh R; Elkord E
Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
[TBL] [Abstract][Full Text] [Related]
9. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
10. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C
Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301
[TBL] [Abstract][Full Text] [Related]
11. From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy.
Osipov A; Murphy A; Zheng L
Adv Cancer Res; 2019; 143():63-144. PubMed ID: 31202363
[TBL] [Abstract][Full Text] [Related]
12. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
13. Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance.
Yao L; Wang Q; Ma W
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136402
[TBL] [Abstract][Full Text] [Related]
14. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
Wang DK; Zuo Q; He QY; Li B
Front Immunol; 2021; 12():705999. PubMed ID: 34447376
[TBL] [Abstract][Full Text] [Related]
15. Neoantigens and their clinical applications in human gastrointestinal cancers.
Eshkiki ZS; Agah S; Tabaeian SP; Sedaghat M; Dana F; Talebi A; Akbari A
World J Surg Oncol; 2022 Sep; 20(1):321. PubMed ID: 36171610
[TBL] [Abstract][Full Text] [Related]
16. Targeting the immune milieu in gastrointestinal cancers.
Turkes F; Mencel J; Starling N
J Gastroenterol; 2020 Oct; 55(10):909-926. PubMed ID: 32748171
[TBL] [Abstract][Full Text] [Related]
17.
Li L; Li M; Jiang Z; Wang X
Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
[TBL] [Abstract][Full Text] [Related]
18. Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities.
Jeong S; Afroz S; Kang D; Noh J; Suh J; Kim JH; You HJ; Kang HG; Kim YJ; Kim JH
Mol Cells; 2023 Oct; 46(10):579-588. PubMed ID: 37853684
[TBL] [Abstract][Full Text] [Related]
19. Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response.
Coschi CH; Juergens RA
Curr Oncol; 2023 Dec; 31(1):1-23. PubMed ID: 38275827
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks.
Meng L; Wu H; Wu J; Ding P; He J; Sang M; Liu L
Cell Death Dis; 2024 Jan; 15(1):3. PubMed ID: 38177102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
